drugset / Trial / NCT03482180
Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled
RandomizedParallel-groupDouble-blindTreatment
Summary
To examine variation rate of Non-HDL with KI1106 comparison Atorvastatin monotherapy.
Timeline
- Start
- 2016-05-04
- Primary completion
- 2017-05-16
- Completion
- 2018-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 20 mg | — |
| Subject | KI1106 | Unknown | 4 g | — |